PETALING JAYA: GlaxoSmithKline (GSK) Pharmaceutical Sdn Bhd has updated the Drug Control Authority of the Health Ministry on the decision taken by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) regarding the drug Avandia.
The company said it would continue to work closely with the authority on its evaluation of the drug.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!